New Covid-19 vaccine demonstrates ‘89% efficacy’
An experimental Covid-19 vaccine appears to offer strong protection in late-stage UK and South Africa studies, said manufacturer Novavax. The UK has secured access to 60 million doses of the vaccine, called NVX-CoV2373.
More Videos
